Thomas McNaughton's Net Worth
$343 Thousand
Who is Thomas McNaughton?
Thomas McNaughton does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HARVARD BIOSCIENCE INC, and Harvard Apparatus Regenerative Technology, Inc..
SEC CIK
Thomas McNaughton's CIK is 0001449450
Past Insider Trading and Trends
2013 was Thomas McNaughton's most active year for acquiring shares with 17 total transactions. Thomas McNaughton's most active month to acquire stocks was the month of October. 2011 was Thomas McNaughton's most active year for disposing of shares, totalling 1 transactions. Thomas McNaughton's most active month to dispose stocks was the month of December. 2009 saw Thomas McNaughton paying a total of $636,000.00 for 200,000 shares, this is the most they've acquired in one year. In 2011 Thomas McNaughton cashed out on 5,990 shares for a total of $24,439.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HARVARD BIOSCIENCE INC (HBIO) Snapshot price: $2.71
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.21% | 25.19K |
—
|
—
| 171.61K |
Nov 1
| |||
Form 4
| +15.22% | 19.34K |
—
|
—
| 146.42K |
May 31
| |||
Form 4
| +48.10% | 41.27K |
—
|
—
| 127.08K |
Jun 1
| |||
Form 4
| +41.11% | 25K |
—
|
—
| 85.81K |
Jun 2
| |||
Form 4
| -8.97% | -5.99K |
$4.08 | -$24,439.20 | 60.81K |
Jan 25
| |||
Form 4
|
∞
| 66.8K |
—
|
—
| 66.8K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Biostage, Inc. (HRGN) Snapshot price: $5.53
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +22.25% | 2.5K |
$4.40 | $11,000.00 | 13.73K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
| +9.00% | 928 |
—
|
—
| 11.23K |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
| +2.49% | 5K |
$1.56 | $7,775.00 | 206.13K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +5.23% | 10K |
$1.70 | $17,000.00 | 201.13K |
Nov 19
| |||
Form 4
| +5.52% | 10K |
$1.56 | $15,600.00 | 191.13K |
Nov 18
| |||
Form 4
| +9.03% | 15K |
$1.32 | $19,800.00 | 181.13K |
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
| +6.41% | 10K |
$0.88 | $8,800.00 | 166.13K |
Aug 26
| |||
Form 4
| +178.16% | 100K |
$0.66 | $65,500.00 | 156.13K |
Aug 19 - Aug 21
| |||
Form 4
| +39.87% | 16K |
$1.85 | $29,670.00 | 56.13K |
Jun 1 - Jun 3
| |||
Form 4
| +14.23% | 5K |
$1.91 | $9,550.00 | 40.13K |
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
| +66.26% | 14K |
$2.67 | $37,380.00 | 35.13K |
Feb 12 - Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
∞
| 21.13K |
—
|
—
| 21.13K |
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |